260 related articles for article (PubMed ID: 31430565)
41. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
[TBL] [Abstract][Full Text] [Related]
42. Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases.
Kawahara M; Kato-Negishi M; Tanaka K
Metallomics; 2017 Jun; 9(6):619-633. PubMed ID: 28516990
[TBL] [Abstract][Full Text] [Related]
43. The C-terminus of the beta protein is critical in amyloidogenesis.
Jarrett JT; Berger EP; Lansbury PT
Ann N Y Acad Sci; 1993 Sep; 695():144-8. PubMed ID: 8239273
[TBL] [Abstract][Full Text] [Related]
44. Preclinical Model to Evaluate Outcomes of Amyloid Cross-Toxicity in the Rodent Brain.
Henríquez G; Méndez L; Castañeda E; Wagler A; Jeon S; Narayan M
ACS Chem Neurosci; 2022 Oct; 13(20):2962-2973. PubMed ID: 36194532
[TBL] [Abstract][Full Text] [Related]
45. Tyrosine-Generated Nanostructures Initiate Amyloid Cross-Seeding in Proteins Leading to a Lethal Aggregation Trap.
Anand BG; Prajapati KP; Shekhawat DS; Kar K
Biochemistry; 2018 Sep; 57(35):5202-5209. PubMed ID: 30080038
[TBL] [Abstract][Full Text] [Related]
46. Endogenous mouse huntingtin is highly abundant in cranial nerve nuclei, co-aggregates to Abeta plaques and is induced in reactive astrocytes in a transgenic mouse model of Alzheimer's disease.
Hartlage-Rübsamen M; Ratz V; Zeitschel U; Finzel L; Machner L; Köppen J; Schulze A; Demuth HU; von Hörsten S; Höfling C; Roßner S
Acta Neuropathol Commun; 2019 May; 7(1):79. PubMed ID: 31109380
[TBL] [Abstract][Full Text] [Related]
47. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
48. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
49. Amyloids and Amyloid-like Protein Aggregates in Foods: Challenges and New Perspectives.
Malik S; Yadav JK
Curr Protein Pept Sci; 2023; 24(5):393-403. PubMed ID: 36600621
[TBL] [Abstract][Full Text] [Related]
50. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
51. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
Kaya I; Zetterberg H; Blennow K; Hanrieder J
ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
[TBL] [Abstract][Full Text] [Related]
52. Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.
Díaz-Nido J; Wandosell F; Avila J
Peptides; 2002 Jul; 23(7):1323-32. PubMed ID: 12128089
[TBL] [Abstract][Full Text] [Related]
53. Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer's and neurodegenerative diseases.
Ayyalasomayajula N; Suresh C
Nutr Neurosci; 2018 Dec; 21(10):682-694. PubMed ID: 28683598
[TBL] [Abstract][Full Text] [Related]
54. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
Gerszon J; Rodacka A
Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
[TBL] [Abstract][Full Text] [Related]
55. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
56. Three-Dimensional Study of Alzheimer's Disease Hallmarks Using the iDISCO Clearing Method.
Liebmann T; Renier N; Bettayeb K; Greengard P; Tessier-Lavigne M; Flajolet M
Cell Rep; 2016 Jul; 16(4):1138-1152. PubMed ID: 27425620
[TBL] [Abstract][Full Text] [Related]
57. Intranasally Administered S100A9 Amyloids Induced Cellular Stress, Amyloid Seeding, and Behavioral Impairment in Aged Mice.
Iashchishyn IA; Gruden MA; Moskalenko RA; Davydova TV; Wang C; Sewell RDE; Morozova-Roche LA
ACS Chem Neurosci; 2018 Jun; 9(6):1338-1348. PubMed ID: 29618200
[TBL] [Abstract][Full Text] [Related]
58. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
59. Exploring critical determinants of protein amyloidogenesis: a review.
Sarkar N; Dubey VK
J Pept Sci; 2013 Sep; 19(9):529-36. PubMed ID: 23873708
[TBL] [Abstract][Full Text] [Related]
60. Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.
Kulikova AA; Cheglakov IB; Kukharsky MS; Ovchinnikov RK; Kozin SA; Makarov AA
Neurotox Res; 2016 May; 29(4):551-7. PubMed ID: 26842600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
